Pnc Financial Services Group, Inc. Cabaletta Bio, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $153 Billion
- Q2 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,309 shares of CABA stock, worth $4,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,309
Previous 154
750.0%
Holding current value
$4,725
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CABA
# of Institutions
92Shares Held
79.3MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$34.9 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$31.9 Million0.02% of portfolio
-
Jennison Associates LLC8.5MShares$30.7 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$24.5 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$18.1 Million0.77% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $105M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...